Nagavarakishore Pillarsetty, Ph.D. - Publications

2003 University of Missouri - Columbia, Columbia, MO, United States 
Inorganic Chemistry, Organic Chemistry, Nuclear Chemistry, Biomedical Engineering

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Salinas B, Irwin CP, Kossatz S, Bolaender A, Chiosis G, Pillarsetty N, Weber WA, Reiner T. Radioiodinated PARP1 tracers for glioblastoma imaging. Ejnmmi Research. 5: 123. PMID 26337803 DOI: 10.1186/s13550-015-0123-1  0.4
2014 Daumar P, Zeglis BM, Ramos N, Divilov V, Sevak KK, Pillarsetty N, Lewis JS. Synthesis and evaluation of (18)F-labeled ATP competitive inhibitors of topoisomerase II as probes for imaging topoisomerase II expression. European Journal of Medicinal Chemistry. 86: 769-81. PMID 25240701 DOI: 10.1016/j.ejmech.2014.09.019  0.4
2014 Fernández-Tejada A, Chea EK, George C, Pillarsetty N, Gardner JR, Livingston PO, Ragupathi G, Lewis JS, Tan DS, Gin DY. Development of a minimal saponin vaccine adjuvant based on QS-21. Nature Chemistry. 6: 635-43. PMID 24950335 DOI: 10.1038/nchem.1963  0.4
2014 Kim TS, Cavnar MJ, Cohen NA, Sorenson EC, Greer JB, Seifert AM, Crawley MH, Green BL, Popow R, Pillarsetty N, Veach DR, Ku AT, Rossi F, Besmer P, Antonescu CR, et al. Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumor. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 2350-62. PMID 24583793 DOI: 10.1158/1078-0432.CCR-13-3033  0.4
2013 Stelter L, Tseng JC, Torosjan A, Levin B, Longo VA, Pillarsetty N, Zanzonico P, Meruelo D, Larson SM. Tumor-specific targeting with modified Sindbis viral vectors: evaluation with optical imaging and positron emission tomography in vivo. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 15: 166-74. PMID 22847302 DOI: 10.1007/s11307-012-0585-8  0.4
2012 Benezra M, Hambardzumyan D, Penate-Medina O, Veach DR, Pillarsetty N, Smith-Jones P, Phillips E, Ozawa T, Zanzonico PB, Longo V, Holland EC, Larson SM, Bradbury MS. Fluorine-labeled dasatinib nanoformulations as targeted molecular imaging probes in a PDGFB-driven murine glioblastoma model. Neoplasia (New York, N.Y.). 14: 1132-43. PMID 23308046 DOI: 10.1593/neo.121750  0.4
2012 Zhang H, Cantorias MV, Pillarsetty N, Burnazi EM, Cai S, Lewis JS. An improved strategy for the synthesis of [¹⁸F]-labeled arabinofuranosyl nucleosides. Nuclear Medicine and Biology. 39: 1182-8. PMID 22819195 DOI: 10.1016/j.nucmedbio.2012.06.008  0.4
2012 Daumar P, Wanger-Baumann CA, Pillarsetty N, Fabrizio L, Carlin SD, Andreev OA, Reshetnyak YK, Lewis JS. Efficient (18)F-labeling of large 37-amino-acid pHLIP peptide analogues and their biological evaluation. Bioconjugate Chemistry. 23: 1557-66. PMID 22784215 DOI: 10.1021/bc3000222  0.4
2012 Dunphy MP, Zanzonico P, Veach D, Somwar R, Pillarsetty N, Lewis J, Larson S. Dosimetry of 18F-labeled tyrosine kinase inhibitor SKI-249380, a dasatinib-tracer for PET imaging. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 14: 25-31. PMID 21161687 DOI: 10.1007/s11307-010-0462-2  0.4
2011 Moulick K, Ahn JH, Zong H, Rodina A, Cerchietti L, Gomes DaGama EM, Caldas-Lopes E, Beebe K, Perna F, Hatzi K, Vu LP, Zhao X, Zatorska D, Taldone T, Smith-Jones P, ... ... Pillarsetty N, et al. Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90. Nature Chemical Biology. 7: 818-26. PMID 21946277 DOI: 10.1038/nchembio.670  0.4
2011 Kannan R, Pillarsetty N, Gali H, Hoffman TJ, Barnes CL, Jurisson SS, Smith CJ, Volkert WA. Design and synthesis of a bombesin peptide-conjugated tripodal phosphino dithioether ligand topology for the stabilization of the fac-[M(CO)3]+ core (M=(99 m)Tc or Re). Inorganic Chemistry. 50: 6210-9. PMID 21591746 DOI: 10.1021/ic200491z  0.4
2010 Doubrovin M, Kochetkova T, Santos E, Veach DR, Smith-Jones P, Pillarsetty N, Balatoni J, Bornmann W, Gelovani J, Larson SM. (124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivo. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 121-9. PMID 20048131 DOI: 10.2967/jnumed.109.066126  0.4
2008 Dobrenkov K, Olszewska M, Likar Y, Shenker L, Gunset G, Cai S, Pillarsetty N, Hricak H, Sadelain M, Ponomarev V. Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 1162-70. PMID 18552144 DOI: 10.2967/jnumed.107.047324  0.4
2007 Veach DR, Namavari M, Pillarsetty N, Santos EB, Beresten-Kochetkov T, Lambek C, Punzalan BJ, Antczak C, Smith-Jones PM, Djaballah H, Clarkson B, Larson SM. Synthesis and biological evaluation of a fluorine-18 derivative of dasatinib. Journal of Medicinal Chemistry. 50: 5853-7. PMID 17956080 DOI: 10.1021/jm070342g  0.4
2005 Pillarsetty N, Raghuraman K, Barnes CL, Katti KV. Design, synthesis, and chemistry of sterically nondemanding primary bisphosphines Journal of the American Chemical Society. 127: 331-336. PMID 15631483 DOI: 10.1021/ja047238y  0.4
2003 Raghuraman K, Katti KK, Barbour LJ, Pillarsetty N, Barnes CL, Katti KV. Characterization of supramolecular (H2O)18 water morphology and water-methanol (H2O)15(CH3OH)3 clusters in a novel phosphorus functionalized trimeric amino acid host Journal of the American Chemical Society. 125: 6955-6961. PMID 12783548 DOI: 10.1021/ja034682c  0.4
2003 Higginbotham ML, Henry CJ, Katti KV, Casteel SW, Dowling PM, Pillarsetty N. Preclinical tolerance and pharmacokinetic assessment of MU-Gold, a novel chemotherapeutic agent, in laboratory dogs. Veterinary Therapeutics : Research in Applied Veterinary Medicine. 4: 76-82. PMID 12756638  0.4
2003 Kothari KK, Raghuraman K, Pillarsetty NK, Hoffman TJ, Owen NK, Katti KV, Volkert WA. Syntheses, in vitro and in vivo characterization of a 99mTc-(I)-tricarbonyl-benzylamino-dihydroxymethyl phosphine (NP(2)) chelate. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 58: 543-9. PMID 12735970 DOI: 10.1016/S0969-8043(03)00030-7  0.4
2003 Pillarsetty N, Katti KK, Hoffman TJ, Volkert WA, Katti KV, Kamei H, Koide T. In vitro and in vivo antitumor properties of tetrakis((trishydroxy- methyl)phosphine)gold(I) chloride. Journal of Medicinal Chemistry. 46: 1130-2. PMID 12646023 DOI: 10.1021/jm025615g  0.4
2002 Raghuraman K, Pillarsetty N, Volkert WA, Barnes C, Jurisson S, Katti KV. Exceptional kinetic propensity of hydroxymethyl phosphanes toward Rh(III) stabilization in water. Journal of the American Chemical Society. 124: 7276-7. PMID 12071729 DOI: 10.1021/ja025987e  0.4
2002 Kothari KK, Gali H, Prabhu KR, Pillarsetty N, Owen NK, Katti KV, Hoffman TJ, Volkert WA. Synthesis and characterization of (99m)Tc- and (188)Re-complexes with a diamido-dihydroxymethylenephosphine-based bifunctional chelating agent (N(2)P(2)-BFCA). Nuclear Medicine and Biology. 29: 83-9. PMID 11786279 DOI: 10.1016/S0969-8051(01)00280-3  0.4
2002 Katti KV, Kannan R, Katti KK, Pillarsetty N, Barnes CL. New phosphorus chemistry leads to unnatural aminoacid trimers Phosphorus, Sulfur and Silicon and Related Elements. 177: 1587-1589. DOI: 10.1080/10426500212214  0.4
Show low-probability matches.